Literature DB >> 33275178

EANM/SNMMI practice guideline for [18F]FDG PET/CT external beam radiotherapy treatment planning in uterine cervical cancer v1.0.

Judit A Adam1, Annika Loft2, Cyrus Chargari3,4,5, Roberto C Delgado Bolton6, Elisabeth Kidd7, Heiko Schöder8, Patrick Veit-Haibach9, Wouter V Vogel10.   

Abstract

PURPOSE: The aim of this EANM / SNMMI Practice Guideline with ESTRO endorsement is to provide general information and specific considerations about [18F]FDG PET/CT in advanced uterine cervical cancer for external beam radiotherapy planning with emphasis on staging and target definition, mostly in FIGO stages IB3-IVA and IVB, treated with curative intention.
METHODS: Guidelines from related fields, relevant literature and leading experts have been consulted during the development of this guideline. As this field is rapidly evolving, this guideline cannot be seen as definitive, nor is it a summary of all existing protocols. Local variations should be taken into consideration when applying this guideline.
CONCLUSION: The background, common clinical indications, qualifications and responsibilities of personnel, procedure / specifications of the examination, documentation / reporting and equipment specifications, quality control and radiation safety in imaging is discussed with an emphasis on the multidisciplinary approach.

Entities:  

Keywords:  Cervical cancer; Guideline; PET/CT; Positron emission tomography; Radiation oncology; Treatment planning; [18F]FDG

Year:  2020        PMID: 33275178     DOI: 10.1007/s00259-020-05112-2

Source DB:  PubMed          Journal:  Eur J Nucl Med Mol Imaging        ISSN: 1619-7070            Impact factor:   9.236


  72 in total

1.  Clinical use of PET-CT data for radiotherapy planning: what are we looking for?

Authors:  Arturo Chiti; Margarita Kirienko; Vincent Grégoire
Journal:  Radiother Oncol       Date:  2010-08-18       Impact factor: 6.280

2.  Staging of uterine cervical cancer with MRI: guidelines of the European Society of Urogenital Radiology.

Authors:  Corinne Balleyguier; E Sala; T Da Cunha; A Bergman; B Brkljacic; F Danza; R Forstner; B Hamm; R Kubik-Huch; C Lopez; R Manfredi; J McHugo; L Oleaga; K Togashi; K Kinkel
Journal:  Eur Radiol       Date:  2010-11-10       Impact factor: 5.315

3.  Revised FIGO staging for carcinoma of the cervix.

Authors:  Sergio Pecorelli; Lucia Zigliani; Franco Odicino
Journal:  Int J Gynaecol Obstet       Date:  2009-04-01       Impact factor: 3.561

Review 4.  Biological imaging in clinical oncology: radiation therapy based on functional imaging.

Authors:  Yo-Liang Lai; Chun-Yi Wu; K S Clifford Chao
Journal:  Int J Clin Oncol       Date:  2016-07-06       Impact factor: 3.402

5.  Cancer of the cervix uteri.

Authors:  Ericka Wiebe; Lynette Denny; Gillian Thomas
Journal:  Int J Gynaecol Obstet       Date:  2012-10       Impact factor: 3.561

Review 6.  Revised FIGO staging for carcinoma of the cervix uteri.

Authors:  Neerja Bhatla; Jonathan S Berek; Mauricio Cuello Fredes; Lynette A Denny; Seija Grenman; Kanishka Karunaratne; Sean T Kehoe; Ikuo Konishi; Alexander B Olawaiye; Jaime Prat; Rengaswamy Sankaranarayanan; James Brierley; David Mutch; Denis Querleu; David Cibula; Michael Quinn; Hennie Botha; Lax Sigurd; Laurel Rice; Hee-Sug Ryu; Hextan Ngan; Johanna Mäenpää; Andri Andrijono; Gatot Purwoto; Amita Maheshwari; Uttam D Bafna; Marie Plante; Jayashree Natarajan
Journal:  Int J Gynaecol Obstet       Date:  2019-01-17       Impact factor: 3.561

7.  Anatomic distribution of fluorodeoxyglucose-avid para-aortic lymph nodes in patients with cervical cancer.

Authors:  Vinita Takiar; Hiral P Fontanilla; Patricia J Eifel; Anuja Jhingran; Patrick Kelly; Revathy B Iyer; Charles F Levenback; Yongbin Zhang; Lei Dong; Ann Klopp
Journal:  Int J Radiat Oncol Biol Phys       Date:  2013-01-17       Impact factor: 7.038

Review 8.  Use of PET and PET/CT for radiation therapy planning: IAEA expert report 2006-2007.

Authors:  Michael MacManus; Ursula Nestle; Kenneth E Rosenzweig; Ignasi Carrio; Cristina Messa; Otakar Belohlavek; Massimo Danna; Tomio Inoue; Elizabeth Deniaud-Alexandre; Stefano Schipani; Naoyuki Watanabe; Maurizio Dondi; Branislav Jeremic
Journal:  Radiother Oncol       Date:  2008-12-25       Impact factor: 6.280

9.  The MRI-Linear Accelerator Consortium: Evidence-Based Clinical Introduction of an Innovation in Radiation Oncology Connecting Researchers, Methodology, Data Collection, Quality Assurance, and Technical Development.

Authors:  Linda G W Kerkmeijer; Clifton D Fuller; Helena M Verkooijen; Marcel Verheij; Ananya Choudhury; Kevin J Harrington; Chris Schultz; Arjun Sahgal; Steven J Frank; Joel Goldwein; Kevin J Brown; Bruce D Minsky; Marco van Vulpen
Journal:  Front Oncol       Date:  2016-10-13       Impact factor: 6.244

Review 10.  A practical review of magnetic resonance imaging for the evaluation and management of cervical cancer.

Authors:  Emma C Fields; Elisabeth Weiss
Journal:  Radiat Oncol       Date:  2016-02-02       Impact factor: 3.481

View more
  3 in total

1.  Implications of the Harmonization of [18F]FDG-PET/CT Imaging for Response Assessment of Treatment in Radiotherapy Planning.

Authors:  Elisa Jiménez-Ortega; Raquel Agüera; Ana Ureba; Marcin Balcerzyk; Amadeo Wals-Zurita; Francisco Javier García-Gómez; Antonio Leal
Journal:  Tomography       Date:  2022-04-12

2.  Clinical Implementation and Initial Experience With a 1.5 Tesla MR-Linac for MR-Guided Radiation Therapy for Gynecologic Cancer: An R-IDEAL Stage 1 and 2a First in Humans Feasibility Study of New Technology Implementation.

Authors:  David S Lakomy; Jinzhong Yang; Sastry Vedam; Jihong Wang; Belinda Lee; Angela Sobremonte; Pamela Castillo; Neil Hughes; Mustefa Mohammedsaid; Anuja Jhingran; Ann H Klopp; Seungtaek Choi; C David Fuller; Lilie L Lin
Journal:  Pract Radiat Oncol       Date:  2022-03-09

Review 3.  A guideline proposal for mice preparation and care in 18F-FDG PET imaging.

Authors:  F M Ribeiro; P M M Correia; A C Santos; J F C A Veloso
Journal:  EJNMMI Res       Date:  2022-08-13       Impact factor: 3.434

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.